172 related articles for article (PubMed ID: 16198621)
1. Clinicopathological significance of oxidative cellular damage in non-alcoholic fatty liver diseases.
Seki S; Kitada T; Sakaguchi H
Hepatol Res; 2005 Oct; 33(2):132-4. PubMed ID: 16198621
[TBL] [Abstract][Full Text] [Related]
2. In situ detection of lipid peroxidation and oxidative DNA damage in non-alcoholic fatty liver diseases.
Seki S; Kitada T; Yamada T; Sakaguchi H; Nakatani K; Wakasa K
J Hepatol; 2002 Jul; 37(1):56-62. PubMed ID: 12076862
[TBL] [Abstract][Full Text] [Related]
3. Pathological significance of oxidative cellular damage in human alcoholic liver disease.
Seki S; Kitada T; Sakaguchi H; Nakatani K; Wakasa K
Histopathology; 2003 Apr; 42(4):365-71. PubMed ID: 12653948
[TBL] [Abstract][Full Text] [Related]
4. Unique features associated with hepatic oxidative DNA damage and DNA methylation in non-alcoholic fatty liver disease.
Nishida N; Yada N; Hagiwara S; Sakurai T; Kitano M; Kudo M
J Gastroenterol Hepatol; 2016 Sep; 31(9):1646-53. PubMed ID: 26875698
[TBL] [Abstract][Full Text] [Related]
5. Oxidative Stress and Antioxidant Biomarkers in Clinical and Experimental Models of Non-Alcoholic Fatty Liver Disease.
Ore A; Akinloye OA
Medicina (Kaunas); 2019 Jan; 55(2):. PubMed ID: 30682878
[TBL] [Abstract][Full Text] [Related]
6. Nocturnal hypoxia-induced oxidative stress promotes progression of pediatric non-alcoholic fatty liver disease.
Sundaram SS; Halbower A; Pan Z; Robbins K; Capocelli KE; Klawitter J; Shearn CT; Sokol RJ
J Hepatol; 2016 Sep; 65(3):560-9. PubMed ID: 27501738
[TBL] [Abstract][Full Text] [Related]
7. Necroptosis is a key pathogenic event in human and experimental murine models of non-alcoholic steatohepatitis.
Afonso MB; Rodrigues PM; Carvalho T; Caridade M; Borralho P; Cortez-Pinto H; Castro RE; Rodrigues CM
Clin Sci (Lond); 2015 Oct; 129(8):721-39. PubMed ID: 26201023
[TBL] [Abstract][Full Text] [Related]
8. Cytoplasmic fine granular expression of 8-hydroxydeoxyguanosine reflects early mitochondrial oxidative DNA damage in nonalcoholic fatty liver disease.
Nomoto K; Tsuneyama K; Takahashi H; Murai Y; Takano Y
Appl Immunohistochem Mol Morphol; 2008 Jan; 16(1):71-5. PubMed ID: 18091316
[TBL] [Abstract][Full Text] [Related]
9. Difference and similarity between non-alcoholic steatohepatitis and alcoholic liver disease.
Kojima H; Sakurai S; Uemura M; Takekawa T; Morimoto H; Tamagawa Y; Fukui H
Alcohol Clin Exp Res; 2005 Dec; 29(12 Suppl):259S-63S. PubMed ID: 16385233
[TBL] [Abstract][Full Text] [Related]
10. Levels of the oxidative stress marker γ-glutamyltranspeptidase at different stages of nonalcoholic fatty liver disease.
Irie M; Sohda T; Iwata K; Kunimoto H; Fukunaga A; Kuno S; Yotsumoto K; Sakurai K; Iwashita H; Hirano G; Ueda SI; Yokoyama K; Morihara D; Nishizawa S; Anan A; Takeyama Y; Sakamoto M; Shakado S; Sakisaka S
J Int Med Res; 2012; 40(3):924-33. PubMed ID: 22906265
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical detection of 4-hydroxy-2-nonenal-modified-protein adducts in human alcoholic liver diseases.
Ohhira M; Ohtake T; Matsumoto A; Saito H; Ikuta K; Fujimoto Y; Ono M; Toyokuni S; Kohgo Y
Alcohol Clin Exp Res; 1998 May; 22(S3 Pt 1):145S-149S. PubMed ID: 9622393
[TBL] [Abstract][Full Text] [Related]
12. Induction of steatohepatitis (NASH) with insulin resistance in wildtype B6 mice by a western-type diet containing soybean oil and cholesterol.
Henkel J; Coleman CD; Schraplau A; Jӧhrens K; Weber D; Castro JP; Hugo M; Schulz TJ; Krämer S; Schürmann A; Püschel GP
Mol Med; 2017 May; 23():70-82. PubMed ID: 28332698
[TBL] [Abstract][Full Text] [Related]
13. Lipid oxidation products in the pathogenesis of non-alcoholic steatohepatitis.
Bellanti F; Villani R; Facciorusso A; Vendemiale G; Serviddio G
Free Radic Biol Med; 2017 Oct; 111():173-185. PubMed ID: 28109892
[TBL] [Abstract][Full Text] [Related]
14. Liver mitochondrial DNA damage and genetic variability of Cytochrome b - a key component of the respirasome - drive the severity of fatty liver disease.
Pirola CJ; Garaycoechea M; Flichman D; Castaño GO; Sookoian S
J Intern Med; 2021 Jan; 289(1):84-96. PubMed ID: 32634278
[TBL] [Abstract][Full Text] [Related]
15. Non-Alcoholic Fatty Liver Disease.
Engin A
Adv Exp Med Biol; 2017; 960():443-467. PubMed ID: 28585211
[TBL] [Abstract][Full Text] [Related]
16. Mitochondrial gene polymorphisms alter hepatic cellular energy metabolism and aggravate diet-induced non-alcoholic steatohepatitis.
Schröder T; Kucharczyk D; Bär F; Pagel R; Derer S; Jendrek ST; Sünderhauf A; Brethack AK; Hirose M; Möller S; Künstner A; Bischof J; Weyers I; Heeren J; Koczan D; Schmid SM; Divanovic S; Giles DA; Adamski J; Fellermann K; Lehnert H; Köhl J; Ibrahim S; Sina C
Mol Metab; 2016 Apr; 5(4):283-295. PubMed ID: 27069868
[TBL] [Abstract][Full Text] [Related]
17. In situ detection of oxidative DNA damage, 8-hydroxydeoxyguanosine, in chronic human liver disease.
Kitada T; Seki S; Iwai S; Yamada T; Sakaguchi H; Wakasa K
J Hepatol; 2001 Nov; 35(5):613-8. PubMed ID: 11690707
[TBL] [Abstract][Full Text] [Related]
18. Oxidized low-density lipoprotein antibodies/high-density lipoprotein cholesterol ratio is linked to advanced non-alcoholic fatty liver disease lean patients.
Ampuero J; Ranchal I; Gallego-Durán R; Pareja MJ; Del Campo JA; Pastor-Ramírez H; Rico MC; Picón R; Pastor L; García-Monzón C; Andrade R; Romero-Gómez M
J Gastroenterol Hepatol; 2016 Sep; 31(9):1611-8. PubMed ID: 26946071
[TBL] [Abstract][Full Text] [Related]
19. CD36 palmitoylation disrupts free fatty acid metabolism and promotes tissue inflammation in non-alcoholic steatohepatitis.
Zhao L; Zhang C; Luo X; Wang P; Zhou W; Zhong S; Xie Y; Jiang Y; Yang P; Tang R; Pan Q; Hall AR; Luong TV; Fan J; Varghese Z; Moorhead JF; Pinzani M; Chen Y; Ruan XZ
J Hepatol; 2018 Sep; 69(3):705-717. PubMed ID: 29705240
[TBL] [Abstract][Full Text] [Related]
20. Uncoupling protein-2 (UCP2) induces mitochondrial proton leak and increases susceptibility of non-alcoholic steatohepatitis (NASH) liver to ischaemia-reperfusion injury.
Serviddio G; Bellanti F; Tamborra R; Rollo T; Capitanio N; Romano AD; Sastre J; Vendemiale G; Altomare E
Gut; 2008 Jul; 57(7):957-65. PubMed ID: 18308829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
